Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Sodium-Potassium-Exchanging ATPase | 29 | 2014 | 479 | 4.950 |
Why?
|
Otosclerosis | 27 | 2016 | 113 | 4.490 |
Why?
|
Muscle Fatigue | 19 | 2015 | 95 | 3.800 |
Why?
|
Temporal Bone | 47 | 2016 | 683 | 3.740 |
Why?
|
Potassium | 22 | 2014 | 1311 | 2.480 |
Why?
|
Physical Endurance | 22 | 2011 | 368 | 2.300 |
Why?
|
Muscle, Skeletal | 46 | 2014 | 4961 | 2.270 |
Why?
|
Exercise | 42 | 2014 | 5937 | 2.160 |
Why?
|
Neuroma, Acoustic | 21 | 2016 | 456 | 1.920 |
Why?
|
Quadriceps Muscle | 8 | 2013 | 157 | 1.590 |
Why?
|
Labyrinth Diseases | 10 | 2016 | 151 | 1.480 |
Why?
|
Semicircular Canals | 12 | 2015 | 203 | 1.470 |
Why?
|
Muscle Contraction | 13 | 2014 | 1206 | 1.390 |
Why?
|
Ear, Inner | 14 | 2016 | 425 | 1.350 |
Why?
|
Acetylcysteine | 6 | 2008 | 262 | 1.310 |
Why?
|
Physical Education and Training | 12 | 2007 | 102 | 1.140 |
Why?
|
Ouabain | 9 | 2012 | 246 | 0.960 |
Why?
|
Hearing Loss, Sensorineural | 15 | 2016 | 781 | 0.940 |
Why?
|
Bone Remodeling | 8 | 2015 | 577 | 0.890 |
Why?
|
Stapes Surgery | 7 | 2016 | 60 | 0.880 |
Why?
|
Altitude | 7 | 2006 | 162 | 0.840 |
Why?
|
Cranial Nerve Neoplasms | 8 | 2016 | 131 | 0.830 |
Why?
|
Mastoid | 6 | 2015 | 100 | 0.780 |
Why?
|
Facial Nerve Diseases | 4 | 2016 | 48 | 0.770 |
Why?
|
Football | 4 | 2015 | 504 | 0.730 |
Why?
|
Hearing Loss, Conductive | 8 | 2016 | 159 | 0.730 |
Why?
|
Muscle Strength | 9 | 2013 | 638 | 0.670 |
Why?
|
Physical Fitness | 8 | 2008 | 742 | 0.640 |
Why?
|
Free Radical Scavengers | 3 | 2006 | 213 | 0.640 |
Why?
|
Athletic Performance | 4 | 2015 | 112 | 0.630 |
Why?
|
Stapes | 6 | 2016 | 89 | 0.630 |
Why?
|
Oxygen Consumption | 21 | 2012 | 1870 | 0.620 |
Why?
|
Collagen Type I | 4 | 2007 | 616 | 0.610 |
Why?
|
Diphosphonates | 5 | 2016 | 625 | 0.600 |
Why?
|
Osteogenesis Imperfecta | 3 | 2007 | 81 | 0.600 |
Why?
|
Vestibular Diseases | 4 | 2008 | 232 | 0.590 |
Why?
|
Exercise Test | 18 | 2012 | 2184 | 0.580 |
Why?
|
Basketball | 6 | 2008 | 43 | 0.580 |
Why?
|
RNA, Messenger | 14 | 2013 | 12767 | 0.570 |
Why?
|
Physical Exertion | 8 | 2010 | 666 | 0.550 |
Why?
|
Ear Neoplasms | 6 | 2008 | 118 | 0.540 |
Why?
|
Hearing Loss | 11 | 2016 | 784 | 0.530 |
Why?
|
Exercise Tolerance | 4 | 2013 | 841 | 0.520 |
Why?
|
Tympanic Membrane | 7 | 2016 | 232 | 0.520 |
Why?
|
Ear, Middle | 9 | 2016 | 341 | 0.520 |
Why?
|
Otitis | 1 | 2016 | 21 | 0.520 |
Why?
|
Otologic Surgical Procedures | 5 | 2015 | 148 | 0.520 |
Why?
|
Adaptation, Physiological | 10 | 2015 | 1308 | 0.510 |
Why?
|
Macrolides | 1 | 2017 | 204 | 0.510 |
Why?
|
Facial Nerve | 7 | 2006 | 277 | 0.480 |
Why?
|
Cochlea | 9 | 2016 | 847 | 0.480 |
Why?
|
Drug Delivery Systems | 9 | 2016 | 2210 | 0.470 |
Why?
|
Antigens, Differentiation, Myelomonocytic | 1 | 2016 | 280 | 0.460 |
Why?
|
Facial Paralysis | 10 | 2010 | 346 | 0.450 |
Why?
|
Measles virus | 6 | 2007 | 67 | 0.450 |
Why?
|
Acid-Base Equilibrium | 7 | 2012 | 180 | 0.430 |
Why?
|
Neurilemmoma | 3 | 2016 | 522 | 0.420 |
Why?
|
Protein Biosynthesis | 2 | 2017 | 2087 | 0.420 |
Why?
|
Weight Lifting | 5 | 2007 | 130 | 0.410 |
Why?
|
Fibrous Dysplasia of Bone | 3 | 2010 | 52 | 0.410 |
Why?
|
Hearing Disorders | 6 | 2015 | 126 | 0.410 |
Why?
|
Renal Dialysis | 4 | 2011 | 1800 | 0.410 |
Why?
|
Fatigue | 10 | 2014 | 1551 | 0.400 |
Why?
|
Adult | 136 | 2016 | 223055 | 0.400 |
Why?
|
Heart-Lung Transplantation | 1 | 2012 | 87 | 0.380 |
Why?
|
Parietal Bone | 2 | 2010 | 49 | 0.370 |
Why?
|
Muscle Fibers, Fast-Twitch | 3 | 2008 | 70 | 0.370 |
Why?
|
Isoenzymes | 5 | 2013 | 1688 | 0.370 |
Why?
|
Male | 157 | 2016 | 363740 | 0.360 |
Why?
|
Running | 9 | 2013 | 489 | 0.360 |
Why?
|
Facial Muscles | 3 | 2005 | 159 | 0.360 |
Why?
|
Glutathione | 2 | 2004 | 589 | 0.360 |
Why?
|
Receptors, Cytoplasmic and Nuclear | 2 | 2006 | 852 | 0.360 |
Why?
|
Body Temperature | 2 | 2013 | 781 | 0.360 |
Why?
|
Bone Density Conservation Agents | 3 | 2016 | 791 | 0.350 |
Why?
|
Hearing | 8 | 2013 | 505 | 0.350 |
Why?
|
Humans | 231 | 2017 | 765823 | 0.350 |
Why?
|
Bicycling | 5 | 2004 | 176 | 0.350 |
Why?
|
Sarcoplasmic Reticulum | 6 | 2004 | 164 | 0.340 |
Why?
|
Calcium | 10 | 2005 | 5767 | 0.340 |
Why?
|
Chlorides | 4 | 2007 | 666 | 0.330 |
Why?
|
Protein Isoforms | 5 | 2008 | 1717 | 0.330 |
Why?
|
Osteoprotegerin | 5 | 2010 | 178 | 0.330 |
Why?
|
Surgical Flaps | 8 | 2008 | 1678 | 0.320 |
Why?
|
Neurofibromatosis 2 | 5 | 2014 | 387 | 0.320 |
Why?
|
Gentamicins | 1 | 2010 | 244 | 0.320 |
Why?
|
Imidazoles | 4 | 2016 | 1164 | 0.320 |
Why?
|
Bone Conduction | 7 | 2016 | 102 | 0.310 |
Why?
|
Audiometry, Pure-Tone | 10 | 2016 | 210 | 0.310 |
Why?
|
Infusion Pumps, Implantable | 1 | 2009 | 158 | 0.300 |
Why?
|
Granuloma, Giant Cell | 3 | 1998 | 32 | 0.300 |
Why?
|
Osteoporosis | 6 | 2008 | 1582 | 0.300 |
Why?
|
Muscle Proteins | 4 | 2011 | 1160 | 0.290 |
Why?
|
Glycoproteins | 2 | 2006 | 2195 | 0.290 |
Why?
|
Ear Canal | 5 | 2007 | 149 | 0.290 |
Why?
|
Lower Extremity | 2 | 2015 | 1226 | 0.280 |
Why?
|
Sports | 4 | 2007 | 699 | 0.280 |
Why?
|
Osteocytes | 2 | 2015 | 193 | 0.280 |
Why?
|
Sodium | 4 | 2007 | 1591 | 0.270 |
Why?
|
Microglia | 1 | 2016 | 1370 | 0.270 |
Why?
|
Tympanoplasty | 4 | 2016 | 73 | 0.270 |
Why?
|
Gene Expression Regulation, Enzymologic | 5 | 2013 | 1166 | 0.270 |
Why?
|
Kidney Transplantation | 2 | 2012 | 4269 | 0.270 |
Why?
|
Electrolytes | 3 | 2002 | 279 | 0.270 |
Why?
|
Hot Temperature | 1 | 2013 | 1433 | 0.270 |
Why?
|
Alkalosis | 2 | 2005 | 55 | 0.270 |
Why?
|
Receptors, Cell Surface | 1 | 2016 | 2817 | 0.260 |
Why?
|
Receptors, Tumor Necrosis Factor | 2 | 2006 | 591 | 0.260 |
Why?
|
Lactic Acid | 14 | 2012 | 1137 | 0.260 |
Why?
|
Skull Neoplasms | 6 | 2007 | 173 | 0.260 |
Why?
|
Perilymph | 5 | 2009 | 50 | 0.260 |
Why?
|
Rest | 4 | 2012 | 940 | 0.250 |
Why?
|
Auditory Threshold | 4 | 2012 | 369 | 0.240 |
Why?
|
Audiometry | 7 | 2016 | 253 | 0.240 |
Why?
|
Antigens, CD | 1 | 2016 | 4020 | 0.240 |
Why?
|
Ear Ossicles | 5 | 2016 | 71 | 0.240 |
Why?
|
Female | 114 | 2016 | 396050 | 0.240 |
Why?
|
Anthropometry | 3 | 2008 | 1339 | 0.230 |
Why?
|
Infusion Pumps | 2 | 2016 | 163 | 0.230 |
Why?
|
Petrous Bone | 3 | 2010 | 85 | 0.230 |
Why?
|
Cochlear Implants | 1 | 2009 | 342 | 0.230 |
Why?
|
Quinoxalines | 4 | 2015 | 296 | 0.230 |
Why?
|
Middle Aged | 81 | 2016 | 223016 | 0.220 |
Why?
|
Tibia | 1 | 2010 | 1064 | 0.220 |
Why?
|
Carcinoid Tumor | 1 | 2005 | 224 | 0.220 |
Why?
|
Sp1 Transcription Factor | 1 | 2004 | 143 | 0.220 |
Why?
|
Otitis Media | 3 | 2004 | 287 | 0.220 |
Why?
|
Neuromuscular Agents | 1 | 2005 | 149 | 0.220 |
Why?
|
Creatine | 3 | 2001 | 424 | 0.220 |
Why?
|
Plasma Volume | 4 | 2014 | 31 | 0.220 |
Why?
|
Cross-Over Studies | 7 | 2012 | 2108 | 0.220 |
Why?
|
Tritium | 3 | 2012 | 702 | 0.210 |
Why?
|
Infusions, Intravenous | 5 | 2008 | 2226 | 0.210 |
Why?
|
Glutathione Disulfide | 1 | 2002 | 32 | 0.210 |
Why?
|
Isometric Contraction | 2 | 2014 | 149 | 0.210 |
Why?
|
Guinea Pigs | 9 | 2016 | 1300 | 0.210 |
Why?
|
Kidney Diseases | 2 | 2011 | 2097 | 0.210 |
Why?
|
Archives | 1 | 2002 | 15 | 0.210 |
Why?
|
Nerve Regeneration | 3 | 2005 | 800 | 0.200 |
Why?
|
Immersion | 2 | 2012 | 38 | 0.200 |
Why?
|
Cysteine | 2 | 2004 | 898 | 0.200 |
Why?
|
Microfluidics | 3 | 2015 | 651 | 0.200 |
Why?
|
Enzyme Activation | 6 | 2007 | 3585 | 0.200 |
Why?
|
Polymerase Chain Reaction | 6 | 2010 | 6061 | 0.190 |
Why?
|
Gene Expression Regulation | 3 | 2010 | 11888 | 0.190 |
Why?
|
Botulinum Toxins, Type A | 1 | 2005 | 239 | 0.190 |
Why?
|
Macrophages | 2 | 2016 | 5771 | 0.190 |
Why?
|
Cell Adhesion Molecules, Neuronal | 2 | 2013 | 262 | 0.190 |
Why?
|
Cytosol | 2 | 2017 | 885 | 0.180 |
Why?
|
Botulinum Toxins | 2 | 1993 | 191 | 0.180 |
Why?
|
Double-Blind Method | 11 | 2013 | 12421 | 0.180 |
Why?
|
Osteoporosis, Postmenopausal | 1 | 2004 | 399 | 0.180 |
Why?
|
Medical Audit | 1 | 2002 | 454 | 0.180 |
Why?
|
Reactive Oxygen Species | 2 | 2006 | 2141 | 0.180 |
Why?
|
Oval Window, Ear | 3 | 2016 | 21 | 0.180 |
Why?
|
Aged | 54 | 2016 | 171178 | 0.180 |
Why?
|
Membrane Proteins | 2 | 2017 | 7846 | 0.180 |
Why?
|
Utilization Review | 1 | 2002 | 381 | 0.180 |
Why?
|
Retrospective Studies | 45 | 2016 | 81505 | 0.180 |
Why?
|
Cerebrospinal Fluid Otorrhea | 1 | 2000 | 16 | 0.170 |
Why?
|
Cation Transport Proteins | 2 | 2013 | 325 | 0.170 |
Why?
|
Hydrogen-Ion Concentration | 10 | 2012 | 2477 | 0.170 |
Why?
|
Antioxidants | 1 | 2008 | 1670 | 0.170 |
Why?
|
Liver Transplantation | 1 | 2012 | 2417 | 0.170 |
Why?
|
Excitatory Amino Acid Antagonists | 4 | 2011 | 450 | 0.170 |
Why?
|
Calcium-Transporting ATPases | 4 | 2003 | 122 | 0.170 |
Why?
|
Tomography, X-Ray Computed | 16 | 2015 | 20680 | 0.170 |
Why?
|
Biopsy | 9 | 2013 | 6765 | 0.170 |
Why?
|
Heart Transplantation | 2 | 2012 | 3310 | 0.160 |
Why?
|
Vertigo | 4 | 2012 | 205 | 0.160 |
Why?
|
Meningitis, Viral | 1 | 1999 | 49 | 0.160 |
Why?
|
Time Factors | 20 | 2012 | 40109 | 0.160 |
Why?
|
Calpain | 2 | 2011 | 145 | 0.160 |
Why?
|
Adenosine Triphosphatases | 2 | 2013 | 837 | 0.150 |
Why?
|
Young Adult | 22 | 2016 | 59849 | 0.150 |
Why?
|
Osmolar Concentration | 3 | 2005 | 655 | 0.150 |
Why?
|
Ear | 2 | 2001 | 172 | 0.150 |
Why?
|
Vestibule, Labyrinth | 3 | 2016 | 234 | 0.150 |
Why?
|
DNA-Binding Proteins | 1 | 2016 | 9594 | 0.150 |
Why?
|
Polymorphism, Genetic | 3 | 2004 | 4249 | 0.150 |
Why?
|
Hearing Tests | 2 | 2010 | 123 | 0.150 |
Why?
|
Brain Abscess | 1 | 1999 | 122 | 0.150 |
Why?
|
Speech Perception | 5 | 2016 | 512 | 0.150 |
Why?
|
Arsenite Transporting ATPases | 1 | 2017 | 5 | 0.150 |
Why?
|
Research | 1 | 2006 | 1974 | 0.150 |
Why?
|
Adolescent | 40 | 2016 | 88794 | 0.150 |
Why?
|
Radiography | 6 | 2013 | 6941 | 0.150 |
Why?
|
Blood Volume | 5 | 2005 | 542 | 0.140 |
Why?
|
Neurologic Examination | 1 | 2001 | 913 | 0.140 |
Why?
|
Osteoarthritis, Knee | 3 | 2013 | 1248 | 0.140 |
Why?
|
Adenoidectomy | 1 | 1999 | 171 | 0.140 |
Why?
|
Mumps | 1 | 1997 | 71 | 0.140 |
Why?
|
Ossicular Prosthesis | 4 | 2016 | 36 | 0.140 |
Why?
|
Choroid Plexus Neoplasms | 1 | 1997 | 38 | 0.140 |
Why?
|
Radiosurgery | 3 | 2014 | 1328 | 0.140 |
Why?
|
Measles | 2 | 2003 | 180 | 0.140 |
Why?
|
Imaging, Three-Dimensional | 2 | 2011 | 4036 | 0.130 |
Why?
|
Treatment Outcome | 26 | 2015 | 65223 | 0.130 |
Why?
|
Endolymphatic Hydrops | 1 | 2016 | 31 | 0.130 |
Why?
|
Aging | 2 | 2012 | 8731 | 0.130 |
Why?
|
Evoked Potentials, Auditory, Brain Stem | 4 | 2006 | 256 | 0.130 |
Why?
|
Stapes Mobilization | 1 | 2016 | 8 | 0.130 |
Why?
|
Muscles | 5 | 2003 | 1578 | 0.130 |
Why?
|
Endolymphatic Sac | 1 | 1997 | 49 | 0.130 |
Why?
|
Binding Sites | 4 | 2012 | 5999 | 0.130 |
Why?
|
Soccer | 2 | 2011 | 142 | 0.130 |
Why?
|
Pulmonary Gas Exchange | 2 | 2000 | 389 | 0.130 |
Why?
|
Hearing Loss, High-Frequency | 1 | 2016 | 11 | 0.130 |
Why?
|
Vestibular Nerve | 2 | 1996 | 101 | 0.130 |
Why?
|
Lung Transplantation | 2 | 2003 | 1311 | 0.130 |
Why?
|
Papilloma | 1 | 1997 | 141 | 0.130 |
Why?
|
Aged, 80 and over | 21 | 2015 | 59506 | 0.130 |
Why?
|
Animals | 35 | 2016 | 168730 | 0.130 |
Why?
|
Otitis Externa | 1 | 1995 | 17 | 0.130 |
Why?
|
Receptor Activator of Nuclear Factor-kappa B | 2 | 2007 | 79 | 0.130 |
Why?
|
Kidney Failure, Chronic | 4 | 2009 | 2498 | 0.120 |
Why?
|
Occipital Bone | 2 | 1996 | 55 | 0.120 |
Why?
|
Colon, Sigmoid | 1 | 1996 | 124 | 0.120 |
Why?
|
Holography | 1 | 2016 | 80 | 0.120 |
Why?
|
Disability Evaluation | 2 | 2011 | 1821 | 0.120 |
Why?
|
Drug Dosage Calculations | 1 | 2016 | 116 | 0.120 |
Why?
|
Case-Control Studies | 7 | 2013 | 22227 | 0.120 |
Why?
|
Tonsillectomy | 1 | 1999 | 284 | 0.120 |
Why?
|
Hemoglobins | 6 | 2006 | 1529 | 0.120 |
Why?
|
Arm | 2 | 2005 | 589 | 0.120 |
Why?
|
Hyperkalemia | 2 | 2014 | 233 | 0.120 |
Why?
|
Chronic Disease | 10 | 2011 | 9355 | 0.120 |
Why?
|
Labyrinthitis | 1 | 2015 | 32 | 0.120 |
Why?
|
Patient Admission | 1 | 2002 | 1364 | 0.120 |
Why?
|
Postoperative Hemorrhage | 1 | 1999 | 413 | 0.120 |
Why?
|
Prealbumin | 1 | 1997 | 266 | 0.120 |
Why?
|
Vestibular Evoked Myogenic Potentials | 2 | 2012 | 88 | 0.120 |
Why?
|
Reverse Transcriptase Polymerase Chain Reaction | 6 | 2012 | 4562 | 0.120 |
Why?
|
Pseudomonas Infections | 1 | 1999 | 622 | 0.120 |
Why?
|
Dizziness | 2 | 2015 | 269 | 0.110 |
Why?
|
Facial Expression | 3 | 2005 | 514 | 0.110 |
Why?
|
Vascular Cell Adhesion Molecule-1 | 1 | 2017 | 694 | 0.110 |
Why?
|
Ear Diseases | 2 | 2012 | 179 | 0.110 |
Why?
|
Point Mutation | 2 | 2001 | 1590 | 0.110 |
Why?
|
Interferon-alpha | 2 | 2016 | 910 | 0.110 |
Why?
|
Skull Base Neoplasms | 2 | 2008 | 276 | 0.110 |
Why?
|
Hepatitis C | 2 | 2016 | 1596 | 0.110 |
Why?
|
RANK Ligand | 2 | 2007 | 320 | 0.110 |
Why?
|
Sound | 1 | 2016 | 257 | 0.110 |
Why?
|
Skin Diseases | 1 | 2002 | 1082 | 0.110 |
Why?
|
Enzyme Inhibitors | 3 | 2005 | 3716 | 0.110 |
Why?
|
Bone Density | 7 | 2008 | 3490 | 0.110 |
Why?
|
Aspirin | 2 | 2016 | 3135 | 0.110 |
Why?
|
Connective Tissue | 1 | 2016 | 425 | 0.110 |
Why?
|
Rats, Wistar | 3 | 2008 | 1884 | 0.110 |
Why?
|
Spasm | 2 | 1995 | 131 | 0.110 |
Why?
|
Electric Stimulation | 4 | 2008 | 1736 | 0.110 |
Why?
|
Alleles | 2 | 2002 | 6893 | 0.110 |
Why?
|
Inflammation Mediators | 2 | 2012 | 1885 | 0.110 |
Why?
|
Diabetes Mellitus, Type 1 | 4 | 2008 | 3444 | 0.110 |
Why?
|
Blepharospasm | 1 | 1993 | 34 | 0.100 |
Why?
|
Polyethylene Glycols | 2 | 2016 | 1188 | 0.100 |
Why?
|
Hydrotherapy | 1 | 2012 | 6 | 0.100 |
Why?
|
Osteoblasts | 4 | 2007 | 1143 | 0.100 |
Why?
|
Etidronic Acid | 1 | 2012 | 63 | 0.100 |
Why?
|
Postoperative Complications | 14 | 2006 | 15794 | 0.100 |
Why?
|
DNA Damage | 1 | 2002 | 2462 | 0.100 |
Why?
|
Mitochondria, Muscle | 2 | 2012 | 170 | 0.100 |
Why?
|
Otoacoustic Emissions, Spontaneous | 5 | 2016 | 139 | 0.100 |
Why?
|
Rats | 9 | 2008 | 23707 | 0.100 |
Why?
|
Dermatology | 1 | 2002 | 905 | 0.100 |
Why?
|
Ossification, Heterotopic | 1 | 2015 | 239 | 0.100 |
Why?
|
Bandages | 1 | 1994 | 269 | 0.100 |
Why?
|
Sex Factors | 4 | 2013 | 10607 | 0.100 |
Why?
|
Epithelium | 2 | 2016 | 1602 | 0.100 |
Why?
|
Collodion | 2 | 1997 | 33 | 0.100 |
Why?
|
Gene Amplification | 1 | 1996 | 1089 | 0.100 |
Why?
|
Antiviral Agents | 2 | 2016 | 3051 | 0.100 |
Why?
|
Actins | 2 | 2016 | 2057 | 0.100 |
Why?
|
Vestibulocochlear Nerve | 4 | 2013 | 115 | 0.100 |
Why?
|
Facial Asymmetry | 1 | 1992 | 173 | 0.100 |
Why?
|
Angiogenesis Inducing Agents | 2 | 2006 | 254 | 0.100 |
Why?
|
Anti-Bacterial Agents | 2 | 2010 | 7476 | 0.100 |
Why?
|
Diagnosis, Differential | 9 | 2016 | 12966 | 0.100 |
Why?
|
Lab-On-A-Chip Devices | 1 | 2016 | 426 | 0.090 |
Why?
|
Pulmonary Ventilation | 3 | 2005 | 376 | 0.090 |
Why?
|
Cryotherapy | 1 | 2012 | 164 | 0.090 |
Why?
|
Susac Syndrome | 1 | 2011 | 22 | 0.090 |
Why?
|
Age Factors | 3 | 2013 | 18380 | 0.090 |
Why?
|
Blotting, Western | 4 | 2012 | 5018 | 0.090 |
Why?
|
Otolaryngology | 3 | 2008 | 698 | 0.090 |
Why?
|
Cranial Sinuses | 1 | 2011 | 68 | 0.090 |
Why?
|
Scala Tympani | 1 | 2011 | 36 | 0.090 |
Why?
|
Heart Rate | 5 | 2011 | 4202 | 0.090 |
Why?
|
Analysis of Variance | 6 | 2012 | 6204 | 0.090 |
Why?
|
Fibroblast Growth Factor 2 | 1 | 2013 | 592 | 0.090 |
Why?
|
Calcium-Binding Proteins | 1 | 2016 | 1077 | 0.090 |
Why?
|
Malleus | 2 | 2007 | 27 | 0.090 |
Why?
|
Glycogen | 5 | 2003 | 251 | 0.090 |
Why?
|
Acoustic Stimulation | 4 | 2016 | 1254 | 0.090 |
Why?
|
Endoplasmic Reticulum | 1 | 2017 | 1132 | 0.090 |
Why?
|
Osteitis Deformans | 1 | 2010 | 54 | 0.090 |
Why?
|
Estrogen Replacement Therapy | 1 | 1997 | 1206 | 0.090 |
Why?
|
Immunohistochemistry | 7 | 2016 | 11033 | 0.090 |
Why?
|
Microfilament Proteins | 1 | 2016 | 1130 | 0.090 |
Why?
|
Phosphocreatine | 4 | 2012 | 258 | 0.090 |
Why?
|
Somatosensory Cortex | 3 | 1999 | 510 | 0.090 |
Why?
|
Protein Transport | 2 | 2017 | 1937 | 0.090 |
Why?
|
Bone Morphogenetic Protein 3 | 1 | 2010 | 17 | 0.090 |
Why?
|
Statistics as Topic | 1 | 2016 | 2350 | 0.090 |
Why?
|
Syndrome | 4 | 2014 | 3269 | 0.080 |
Why?
|
Adenoma, Pleomorphic | 1 | 2010 | 77 | 0.080 |
Why?
|
Osteomalacia | 3 | 1986 | 60 | 0.080 |
Why?
|
Acceleration | 1 | 2010 | 189 | 0.080 |
Why?
|
Microfluidic Analytical Techniques | 1 | 2016 | 788 | 0.080 |
Why?
|
Pediatric Nursing | 1 | 1991 | 104 | 0.080 |
Why?
|
Disease Progression | 6 | 2016 | 13613 | 0.080 |
Why?
|
Bone Morphogenetic Protein Receptors, Type I | 1 | 2010 | 97 | 0.080 |
Why?
|
Myositis | 1 | 2012 | 270 | 0.080 |
Why?
|
Arteries | 1 | 2014 | 1124 | 0.080 |
Why?
|
Quality-Adjusted Life Years | 1 | 2015 | 1740 | 0.080 |
Why?
|
Magnetic Resonance Imaging | 16 | 2016 | 36542 | 0.080 |
Why?
|
Parotid Neoplasms | 1 | 2010 | 157 | 0.080 |
Why?
|
Reference Values | 4 | 2007 | 4911 | 0.080 |
Why?
|
Patient Education as Topic | 2 | 2007 | 2331 | 0.080 |
Why?
|
DNA | 1 | 2002 | 7197 | 0.080 |
Why?
|
Antigens, Viral | 2 | 1990 | 995 | 0.080 |
Why?
|
Genetic Predisposition to Disease | 3 | 2007 | 18064 | 0.080 |
Why?
|
Bone Banks | 1 | 2008 | 4 | 0.080 |
Why?
|
Salicylates | 2 | 2005 | 125 | 0.080 |
Why?
|
Walking | 2 | 2011 | 1198 | 0.080 |
Why?
|
Recombinant Proteins | 4 | 2016 | 6489 | 0.070 |
Why?
|
Insulin | 1 | 2003 | 6601 | 0.070 |
Why?
|
Tumor Burden | 1 | 2014 | 1890 | 0.070 |
Why?
|
Blood Glucose | 6 | 2012 | 6422 | 0.070 |
Why?
|
Biological Availability | 2 | 2009 | 388 | 0.070 |
Why?
|
Ankle | 1 | 1991 | 354 | 0.070 |
Why?
|
Lung Diseases, Obstructive | 1 | 1988 | 309 | 0.070 |
Why?
|
Dietary Supplements | 2 | 1999 | 3425 | 0.070 |
Why?
|
RNA, Viral | 3 | 2013 | 2863 | 0.070 |
Why?
|
Cadaver | 3 | 2016 | 1362 | 0.070 |
Why?
|
Watchful Waiting | 1 | 2011 | 493 | 0.070 |
Why?
|
Capsid | 2 | 1990 | 435 | 0.070 |
Why?
|
Cyclophilins | 1 | 2007 | 47 | 0.070 |
Why?
|
Follow-Up Studies | 14 | 2012 | 39226 | 0.070 |
Why?
|
Bone Neoplasms | 2 | 1997 | 2562 | 0.070 |
Why?
|
Glomus Jugulare Tumor | 3 | 2000 | 35 | 0.070 |
Why?
|
Vitamin D | 2 | 1999 | 3272 | 0.070 |
Why?
|
Carbon Dioxide | 4 | 2002 | 1137 | 0.070 |
Why?
|
Acidosis | 2 | 2003 | 271 | 0.070 |
Why?
|
Fluoresceins | 1 | 2007 | 234 | 0.070 |
Why?
|
Thyroid Diseases | 1 | 1990 | 385 | 0.070 |
Why?
|
Hematocrit | 3 | 2003 | 622 | 0.070 |
Why?
|
Mice, Inbred C57BL | 5 | 2010 | 22323 | 0.070 |
Why?
|
Bicarbonates | 3 | 2012 | 293 | 0.070 |
Why?
|
Mice, Inbred CBA | 2 | 2005 | 439 | 0.070 |
Why?
|
Pectoralis Muscles | 1 | 2007 | 86 | 0.070 |
Why?
|
Enzyme Induction | 1 | 2007 | 456 | 0.070 |
Why?
|
Interferon-beta | 1 | 2008 | 346 | 0.070 |
Why?
|
Muscle Fibers, Skeletal | 2 | 2004 | 552 | 0.070 |
Why?
|
Cholesteatoma, Middle Ear | 2 | 2004 | 52 | 0.070 |
Why?
|
Clinical Trials, Phase II as Topic | 1 | 2009 | 639 | 0.070 |
Why?
|
Mice | 12 | 2010 | 81788 | 0.070 |
Why?
|
Erythropoietin | 2 | 2009 | 715 | 0.070 |
Why?
|
Glycolysis | 4 | 2000 | 838 | 0.070 |
Why?
|
Preoperative Care | 2 | 2009 | 2244 | 0.060 |
Why?
|
Inclusion Bodies, Viral | 1 | 1986 | 45 | 0.060 |
Why?
|
Adenoma | 1 | 1997 | 2155 | 0.060 |
Why?
|
Gait | 1 | 2011 | 820 | 0.060 |
Why?
|
Cerebrospinal Fluid | 1 | 2009 | 540 | 0.060 |
Why?
|
Membrane Potentials | 2 | 2007 | 1083 | 0.060 |
Why?
|
Regulatory Elements, Transcriptional | 1 | 2007 | 183 | 0.060 |
Why?
|
Age Distribution | 2 | 2004 | 2865 | 0.060 |
Why?
|
Microsurgery | 1 | 2011 | 798 | 0.060 |
Why?
|
Atmosphere Exposure Chambers | 2 | 2005 | 51 | 0.060 |
Why?
|
Gene Expression | 5 | 2011 | 7581 | 0.060 |
Why?
|
In Situ Hybridization | 1 | 2010 | 1885 | 0.060 |
Why?
|
Acclimatization | 2 | 2004 | 113 | 0.060 |
Why?
|
Water | 1 | 2012 | 1417 | 0.060 |
Why?
|
Endocrine System | 1 | 2006 | 110 | 0.060 |
Why?
|
Hepacivirus | 1 | 2013 | 1343 | 0.060 |
Why?
|
Osteoclasts | 3 | 2001 | 713 | 0.060 |
Why?
|
Solutions | 2 | 2004 | 404 | 0.060 |
Why?
|
Sex Cord-Gonadal Stromal Tumors | 1 | 2007 | 117 | 0.060 |
Why?
|
Ion Channels | 2 | 2005 | 1044 | 0.060 |
Why?
|
Cartilage | 2 | 2007 | 797 | 0.060 |
Why?
|
Optics and Photonics | 1 | 2007 | 305 | 0.060 |
Why?
|
Dyssomnias | 1 | 2005 | 28 | 0.060 |
Why?
|
Postoperative Period | 3 | 2003 | 1817 | 0.060 |
Why?
|
Management Audit | 1 | 2005 | 23 | 0.060 |
Why?
|
Intestinal Absorption | 1 | 2006 | 400 | 0.060 |
Why?
|
Down-Regulation | 1 | 2012 | 2924 | 0.060 |
Why?
|
Recovery of Function | 2 | 2012 | 2965 | 0.060 |
Why?
|
Body Size | 1 | 2008 | 459 | 0.060 |
Why?
|
Muscle Fibers, Slow-Twitch | 2 | 2002 | 52 | 0.060 |
Why?
|
Registries | 4 | 2008 | 8320 | 0.060 |
Why?
|
Tosyl Compounds | 1 | 2005 | 115 | 0.060 |
Why?
|
Craniotomy | 3 | 1998 | 731 | 0.060 |
Why?
|
Hemangioma | 1 | 2010 | 724 | 0.060 |
Why?
|
Prostatitis | 1 | 2005 | 102 | 0.060 |
Why?
|
Ireland | 3 | 2008 | 171 | 0.060 |
Why?
|
Leukotriene Antagonists | 1 | 2005 | 124 | 0.060 |
Why?
|
Energy Metabolism | 4 | 1999 | 2891 | 0.060 |
Why?
|
Altitude Sickness | 1 | 2005 | 93 | 0.060 |
Why?
|
Metabolic Clearance Rate | 1 | 2004 | 360 | 0.060 |
Why?
|
Drug Stability | 1 | 2004 | 289 | 0.060 |
Why?
|
Presbycusis | 1 | 2004 | 43 | 0.060 |
Why?
|
Mice, Inbred Strains | 2 | 2005 | 1770 | 0.060 |
Why?
|
Protein Binding | 2 | 2007 | 9297 | 0.060 |
Why?
|
Anti-Inflammatory Agents, Non-Steroidal | 3 | 2016 | 2269 | 0.060 |
Why?
|
Administration, Oral | 7 | 2009 | 4018 | 0.060 |
Why?
|
Quinazolines | 1 | 2010 | 1365 | 0.060 |
Why?
|
Organ Size | 1 | 2009 | 2260 | 0.060 |
Why?
|
Patient Preference | 1 | 2011 | 947 | 0.060 |
Why?
|
Restriction Mapping | 1 | 2004 | 848 | 0.050 |
Why?
|
Oligopeptides | 1 | 2009 | 1193 | 0.050 |
Why?
|
Anemia | 3 | 2009 | 1510 | 0.050 |
Why?
|
Time and Motion Studies | 2 | 2011 | 144 | 0.050 |
Why?
|
Gonadotropin-Releasing Hormone | 1 | 2009 | 1133 | 0.050 |
Why?
|
Motor Activity | 1 | 2013 | 2705 | 0.050 |
Why?
|
Cholesterol, LDL | 1 | 2013 | 2393 | 0.050 |
Why?
|
Oxygen | 4 | 2005 | 4242 | 0.050 |
Why?
|
Microscopy, Electron | 2 | 2001 | 2546 | 0.050 |
Why?
|
Forearm | 1 | 2005 | 426 | 0.050 |
Why?
|
Equipment Design | 4 | 2015 | 3488 | 0.050 |
Why?
|
MELAS Syndrome | 1 | 2003 | 54 | 0.050 |
Why?
|
Thigh | 1 | 2004 | 237 | 0.050 |
Why?
|
Collagen | 2 | 2007 | 2617 | 0.050 |
Why?
|
Peripheral Nerves | 1 | 2006 | 491 | 0.050 |
Why?
|
Orofaciodigital Syndromes | 1 | 2002 | 21 | 0.050 |
Why?
|
Video Recording | 3 | 2007 | 969 | 0.050 |
Why?
|
Stereotaxic Techniques | 1 | 2005 | 551 | 0.050 |
Why?
|
Cell Nucleus | 1 | 2011 | 2864 | 0.050 |
Why?
|
Hospital Information Systems | 1 | 2005 | 395 | 0.050 |
Why?
|
Bone Resorption | 2 | 2001 | 717 | 0.050 |
Why?
|
Cystine | 1 | 2002 | 96 | 0.050 |
Why?
|
Factor Analysis, Statistical | 1 | 2005 | 999 | 0.050 |
Why?
|
Pelvic Pain | 1 | 2005 | 300 | 0.050 |
Why?
|
Fatty Acids | 2 | 2009 | 1806 | 0.050 |
Why?
|
Angiogenesis Inhibitors | 1 | 2012 | 2046 | 0.050 |
Why?
|
Miniaturization | 2 | 2015 | 150 | 0.050 |
Why?
|
Diffusion | 2 | 2016 | 808 | 0.050 |
Why?
|
Exercise Therapy | 1 | 2009 | 937 | 0.050 |
Why?
|
Protein Subunits | 1 | 2005 | 939 | 0.050 |
Why?
|
Sodium Bicarbonate | 1 | 2002 | 59 | 0.050 |
Why?
|
Neoplasm Recurrence, Local | 6 | 2010 | 9372 | 0.050 |
Why?
|
Culture Techniques | 1 | 2002 | 515 | 0.050 |
Why?
|
Models, Biological | 2 | 2016 | 9441 | 0.050 |
Why?
|
Athletic Injuries | 1 | 2012 | 1244 | 0.050 |
Why?
|
Glioma | 1 | 1997 | 3493 | 0.050 |
Why?
|
L-Lactate Dehydrogenase | 1 | 2003 | 411 | 0.050 |
Why?
|
Adenosine Triphosphate | 4 | 2001 | 1999 | 0.050 |
Why?
|
Intracranial Arteriovenous Malformations | 1 | 2005 | 360 | 0.050 |
Why?
|
Polysomnography | 2 | 2005 | 1868 | 0.050 |
Why?
|
Hospital Charges | 1 | 2003 | 345 | 0.050 |
Why?
|
England | 1 | 2002 | 533 | 0.050 |
Why?
|
Vibrissae | 2 | 1999 | 121 | 0.050 |
Why?
|
Child | 14 | 2016 | 80509 | 0.040 |
Why?
|
Intubation, Intratracheal | 1 | 1988 | 1303 | 0.040 |
Why?
|
Severity of Illness Index | 6 | 2005 | 15881 | 0.040 |
Why?
|
Respiratory Function Tests | 1 | 2005 | 1692 | 0.040 |
Why?
|
Multienzyme Complexes | 1 | 2003 | 663 | 0.040 |
Why?
|
Monitoring, Intraoperative | 2 | 2000 | 939 | 0.040 |
Why?
|
Ossicular Replacement | 2 | 2016 | 11 | 0.040 |
Why?
|
Neuronal Plasticity | 2 | 1999 | 1444 | 0.040 |
Why?
|
Enzyme-Linked Immunosorbent Assay | 2 | 2005 | 3802 | 0.040 |
Why?
|
Paraganglioma, Extra-Adrenal | 1 | 2000 | 47 | 0.040 |
Why?
|
Nucleic Acid Amplification Techniques | 1 | 2002 | 335 | 0.040 |
Why?
|
Cytokines | 2 | 2013 | 7425 | 0.040 |
Why?
|
Adrenal Cortex Hormones | 1 | 2008 | 1881 | 0.040 |
Why?
|
Bone Demineralization, Pathologic | 1 | 1999 | 7 | 0.040 |
Why?
|
Haplotypes | 3 | 2007 | 2728 | 0.040 |
Why?
|
Electrophoresis, Polyacrylamide Gel | 1 | 2002 | 1724 | 0.040 |
Why?
|
Immunologic Factors | 1 | 2008 | 1584 | 0.040 |
Why?
|
Immunosuppressive Agents | 2 | 2010 | 4207 | 0.040 |
Why?
|
Perioperative Nursing | 1 | 1999 | 16 | 0.040 |
Why?
|
Kinetics | 3 | 2011 | 6272 | 0.040 |
Why?
|
Pain | 2 | 2012 | 5076 | 0.040 |
Why?
|
Deafness | 1 | 2003 | 460 | 0.040 |
Why?
|
Length of Stay | 2 | 2003 | 6485 | 0.040 |
Why?
|
Ammonia | 3 | 1998 | 244 | 0.040 |
Why?
|
Rats, Sprague-Dawley | 2 | 2008 | 8105 | 0.040 |
Why?
|
Medical Records Systems, Computerized | 1 | 2005 | 1195 | 0.040 |
Why?
|
Models, Animal | 1 | 2005 | 2120 | 0.040 |
Why?
|
Foot | 1 | 2003 | 574 | 0.040 |
Why?
|
Acetyl-CoA Carboxylase | 2 | 2012 | 72 | 0.040 |
Why?
|
DNA, Complementary | 1 | 2002 | 1984 | 0.040 |
Why?
|
Eustachian Tube | 2 | 1998 | 99 | 0.040 |
Why?
|
Temporomandibular Joint | 2 | 1997 | 201 | 0.040 |
Why?
|
Dose-Response Relationship, Drug | 4 | 2013 | 10723 | 0.040 |
Why?
|
Nanoparticles | 1 | 2010 | 1967 | 0.040 |
Why?
|
Up-Regulation | 2 | 2005 | 4133 | 0.040 |
Why?
|
Testosterone | 1 | 2009 | 2495 | 0.040 |
Why?
|
Carcinoma, Adenoid Cystic | 3 | 2008 | 261 | 0.040 |
Why?
|
Peripheral Nervous System Neoplasms | 1 | 1999 | 133 | 0.040 |
Why?
|
DNA, Mitochondrial | 1 | 2003 | 869 | 0.040 |
Why?
|
Carcinoma, Basal Cell | 3 | 2008 | 565 | 0.040 |
Why?
|
Hypoglossal Nerve | 1 | 1999 | 110 | 0.040 |
Why?
|
Sensory Deprivation | 1 | 1998 | 109 | 0.040 |
Why?
|
Interpersonal Relations | 1 | 2005 | 1433 | 0.040 |
Why?
|
Ligands | 1 | 2005 | 3273 | 0.040 |
Why?
|
Computational Biology | 1 | 2010 | 3557 | 0.040 |
Why?
|
Otitis Media, Suppurative | 1 | 1997 | 27 | 0.040 |
Why?
|
X Chromosome | 1 | 2001 | 819 | 0.040 |
Why?
|
Dexamethasone | 1 | 2005 | 1963 | 0.040 |
Why?
|
Fluid Shifts | 1 | 1997 | 20 | 0.040 |
Why?
|
Postoperative Care | 2 | 2003 | 1474 | 0.040 |
Why?
|
DNA Mutational Analysis | 2 | 2003 | 4110 | 0.040 |
Why?
|
Tissue Distribution | 2 | 2016 | 2270 | 0.040 |
Why?
|
Muscle Relaxation | 1 | 1997 | 138 | 0.030 |
Why?
|
Virus Diseases | 1 | 2003 | 717 | 0.030 |
Why?
|
Genes, Dominant | 2 | 1998 | 855 | 0.030 |
Why?
|
Weight Gain | 1 | 2007 | 2355 | 0.030 |
Why?
|
Membrane Transport Proteins | 1 | 2003 | 1029 | 0.030 |
Why?
|
Disease Models, Animal | 2 | 2007 | 18289 | 0.030 |
Why?
|
Vibration | 2 | 2016 | 334 | 0.030 |
Why?
|
Sleep Apnea Syndromes | 1 | 2005 | 983 | 0.030 |
Why?
|
Antineoplastic Agents | 2 | 2010 | 13635 | 0.030 |
Why?
|
Reoperation | 4 | 2006 | 4309 | 0.030 |
Why?
|
Nerve Degeneration | 1 | 2001 | 748 | 0.030 |
Why?
|
Ribonucleases | 1 | 1997 | 265 | 0.030 |
Why?
|
Comorbidity | 1 | 2011 | 10570 | 0.030 |
Why?
|
Biosynthetic Pathways | 1 | 2017 | 138 | 0.030 |
Why?
|
Peptides | 1 | 2008 | 4331 | 0.030 |
Why?
|
Workload | 1 | 2002 | 850 | 0.030 |
Why?
|
Long-Term Potentiation | 1 | 1998 | 290 | 0.030 |
Why?
|
Australia | 2 | 2012 | 1259 | 0.030 |
Why?
|
Cystic Fibrosis | 1 | 2005 | 1287 | 0.030 |
Why?
|
Stroboscopy | 1 | 2016 | 62 | 0.030 |
Why?
|
Glass Ionomer Cements | 1 | 1995 | 18 | 0.030 |
Why?
|
Aluminum Silicates | 1 | 1995 | 24 | 0.030 |
Why?
|
Respiration | 1 | 2002 | 1652 | 0.030 |
Why?
|
DNA Primers | 2 | 1998 | 2823 | 0.030 |
Why?
|
Trigeminal Nerve | 1 | 1997 | 253 | 0.030 |
Why?
|
Mastoiditis | 1 | 1996 | 37 | 0.030 |
Why?
|
Spectrometry, Fluorescence | 1 | 1998 | 697 | 0.030 |
Why?
|
Chromosomes, Human, Pair 14 | 1 | 1996 | 285 | 0.030 |
Why?
|
Cholesteatoma | 1 | 1995 | 28 | 0.030 |
Why?
|
Quality of Life | 3 | 2015 | 13466 | 0.030 |
Why?
|
Audiometry, Evoked Response | 2 | 1992 | 45 | 0.030 |
Why?
|
Cerebrospinal Fluid Rhinorrhea | 1 | 1996 | 87 | 0.030 |
Why?
|
Anatomy, Regional | 1 | 2015 | 4 | 0.030 |
Why?
|
Temporal Muscle | 1 | 1995 | 36 | 0.030 |
Why?
|
Granuloma, Foreign-Body | 1 | 1995 | 41 | 0.030 |
Why?
|
Fractures, Bone | 1 | 2007 | 2041 | 0.030 |
Why?
|
Dimethylpolysiloxanes | 1 | 2016 | 142 | 0.030 |
Why?
|
Child, Preschool | 8 | 2016 | 42478 | 0.030 |
Why?
|
Research Design | 2 | 2009 | 6207 | 0.030 |
Why?
|
Geniculate Ganglion | 1 | 2015 | 9 | 0.030 |
Why?
|
Carcinoma, Squamous Cell | 4 | 2008 | 4046 | 0.030 |
Why?
|
Proteomics | 1 | 2009 | 3909 | 0.030 |
Why?
|
Cohort Studies | 2 | 2016 | 41643 | 0.030 |
Why?
|
Blood Pressure | 1 | 1991 | 8532 | 0.030 |
Why?
|
Body Surface Area | 1 | 2016 | 206 | 0.030 |
Why?
|
Cranial Fossa, Posterior | 1 | 1995 | 134 | 0.030 |
Why?
|
Drug Administration Routes | 1 | 2015 | 152 | 0.030 |
Why?
|
Headache | 2 | 2011 | 1261 | 0.030 |
Why?
|
Reproducibility of Results | 4 | 2005 | 20131 | 0.030 |
Why?
|
Intracranial Aneurysm | 1 | 2005 | 1271 | 0.030 |
Why?
|
Microtechnology | 1 | 2015 | 64 | 0.030 |
Why?
|
Hypoglycemic Agents | 1 | 2007 | 3107 | 0.030 |
Why?
|
Pressure | 2 | 1998 | 1169 | 0.030 |
Why?
|
Hyperparathyroidism | 1 | 1996 | 337 | 0.030 |
Why?
|
Neoplasm Metastasis | 1 | 2005 | 4883 | 0.030 |
Why?
|
Chromosome Aberrations | 1 | 2001 | 1776 | 0.030 |
Why?
|
Biomimetics | 1 | 2016 | 167 | 0.030 |
Why?
|
Lactates | 1 | 1995 | 398 | 0.030 |
Why?
|
Polytetrafluoroethylene | 1 | 1995 | 242 | 0.030 |
Why?
|
Brain | 5 | 2011 | 27178 | 0.030 |
Why?
|
Hemangiopericytoma | 1 | 1995 | 71 | 0.030 |
Why?
|
Prejudice | 1 | 1999 | 567 | 0.030 |
Why?
|
Meniere Disease | 1 | 1996 | 164 | 0.030 |
Why?
|
Telemetry | 1 | 1995 | 201 | 0.030 |
Why?
|
Athletes | 2 | 2012 | 1162 | 0.030 |
Why?
|
Plasmacytoma | 1 | 1995 | 174 | 0.030 |
Why?
|
von Hippel-Lindau Disease | 1 | 1995 | 154 | 0.030 |
Why?
|
Knee | 1 | 1996 | 272 | 0.030 |
Why?
|
Cochlear Nerve | 2 | 2013 | 202 | 0.030 |
Why?
|
Adenocarcinoma | 3 | 2007 | 6360 | 0.030 |
Why?
|
Polyesters | 1 | 2016 | 373 | 0.030 |
Why?
|
Immobilization | 1 | 1995 | 226 | 0.030 |
Why?
|
Chloramphenicol O-Acetyltransferase | 1 | 1994 | 220 | 0.030 |
Why?
|
Membrane Glycoproteins | 1 | 2005 | 3690 | 0.030 |
Why?
|
Chondrosarcoma | 1 | 1996 | 301 | 0.030 |
Why?
|
Medical Records | 1 | 1999 | 1409 | 0.030 |
Why?
|
Gene Expression Profiling | 1 | 2010 | 9520 | 0.030 |
Why?
|
Socioeconomic Factors | 2 | 2007 | 7840 | 0.030 |
Why?
|
Multiple Sclerosis | 1 | 2008 | 3212 | 0.030 |
Why?
|
Multivariate Analysis | 2 | 2005 | 12056 | 0.030 |
Why?
|
Radiotherapy Dosage | 2 | 2014 | 2863 | 0.030 |
Why?
|
Chordoma | 1 | 1996 | 343 | 0.030 |
Why?
|
Receptors, Drug | 1 | 1993 | 156 | 0.030 |
Why?
|
Acoustic Impedance Tests | 2 | 2004 | 111 | 0.030 |
Why?
|
Bone Transplantation | 1 | 1998 | 920 | 0.030 |
Why?
|
Carnosine | 1 | 2012 | 6 | 0.030 |
Why?
|
Hospital Mortality | 2 | 2005 | 5338 | 0.030 |
Why?
|
Western Australia | 1 | 2012 | 40 | 0.030 |
Why?
|
Meningitis, Bacterial | 1 | 2015 | 222 | 0.030 |
Why?
|
Psychometrics | 2 | 2012 | 3061 | 0.030 |
Why?
|
Mice, Knockout | 2 | 2006 | 14445 | 0.030 |
Why?
|
Nuclear Respiratory Factor 1 | 1 | 2012 | 23 | 0.030 |
Why?
|
Gamma Rays | 1 | 1994 | 324 | 0.020 |
Why?
|
Otorhinolaryngologic Surgical Procedures | 1 | 2015 | 325 | 0.020 |
Why?
|
Social Support | 1 | 2002 | 2191 | 0.020 |
Why?
|
Rectal Neoplasms | 1 | 2001 | 1184 | 0.020 |
Why?
|
Sensation Disorders | 1 | 1993 | 160 | 0.020 |
Why?
|
Body Weight | 2 | 2013 | 4624 | 0.020 |
Why?
|
Models, Economic | 1 | 1996 | 716 | 0.020 |
Why?
|
Motion | 1 | 2016 | 781 | 0.020 |
Why?
|
Critical Care | 1 | 2005 | 2708 | 0.020 |
Why?
|
Ear, External | 2 | 2007 | 164 | 0.020 |
Why?
|
Growth | 1 | 2014 | 365 | 0.020 |
Why?
|
Smiling | 1 | 1992 | 71 | 0.020 |
Why?
|
Cells, Cultured | 2 | 2007 | 18970 | 0.020 |
Why?
|
Blood Gas Analysis | 1 | 1993 | 382 | 0.020 |
Why?
|
Victoria | 1 | 2011 | 64 | 0.020 |
Why?
|
Autolysis | 1 | 2011 | 13 | 0.020 |
Why?
|
Mitogen-Activated Protein Kinase 8 | 1 | 2011 | 71 | 0.020 |
Why?
|
Attention | 1 | 2002 | 2415 | 0.020 |
Why?
|
Blood Proteins | 1 | 1997 | 1186 | 0.020 |
Why?
|
Pilot Projects | 1 | 2005 | 8725 | 0.020 |
Why?
|
Carrier Proteins | 1 | 2005 | 4911 | 0.020 |
Why?
|
Evoked Potentials, Auditory | 2 | 2005 | 529 | 0.020 |
Why?
|
HeLa Cells | 1 | 2017 | 3067 | 0.020 |
Why?
|
Calcium-Calmodulin-Dependent Protein Kinase Type 2 | 1 | 2012 | 179 | 0.020 |
Why?
|
Injections, Intramuscular | 1 | 1992 | 553 | 0.020 |
Why?
|
Fibroblasts | 1 | 2002 | 4160 | 0.020 |
Why?
|
Inflammation | 1 | 2011 | 10845 | 0.020 |
Why?
|
Posture | 1 | 1995 | 955 | 0.020 |
Why?
|
Recurrence | 3 | 1998 | 8506 | 0.020 |
Why?
|
Ribavirin | 1 | 2013 | 395 | 0.020 |
Why?
|
Hearing Loss, Bilateral | 1 | 1991 | 53 | 0.020 |
Why?
|
Antigens, Neoplasm | 2 | 1997 | 1998 | 0.020 |
Why?
|
Fluorescein | 1 | 2011 | 175 | 0.020 |
Why?
|
Ophthalmoscopy | 1 | 2011 | 170 | 0.020 |
Why?
|
Evaluation Studies as Topic | 3 | 1995 | 1606 | 0.020 |
Why?
|
Stress, Mechanical | 1 | 2016 | 1669 | 0.020 |
Why?
|
Myofibrils | 1 | 2011 | 143 | 0.020 |
Why?
|
Vitamin D Deficiency | 2 | 1997 | 1349 | 0.020 |
Why?
|
Bone Diseases | 1 | 1994 | 411 | 0.020 |
Why?
|
Sequence Analysis, DNA | 1 | 2002 | 4772 | 0.020 |
Why?
|
Retinal Artery | 1 | 2011 | 109 | 0.020 |
Why?
|
Transcription Factor RelA | 1 | 2011 | 252 | 0.020 |
Why?
|
Liver Diseases | 1 | 1999 | 1303 | 0.020 |
Why?
|
Emotions | 1 | 2002 | 2759 | 0.020 |
Why?
|
Photons | 1 | 2014 | 572 | 0.020 |
Why?
|
SSPE Virus | 1 | 1990 | 4 | 0.020 |
Why?
|
Carotid Arteries | 1 | 1995 | 937 | 0.020 |
Why?
|
Predictive Value of Tests | 4 | 2016 | 15398 | 0.020 |
Why?
|
Ovarian Neoplasms | 1 | 2007 | 4903 | 0.020 |
Why?
|
Granulocyte-Macrophage Colony-Stimulating Factor | 1 | 1994 | 890 | 0.020 |
Why?
|
Thyroglobulin | 1 | 1990 | 111 | 0.020 |
Why?
|
Anaerobic Threshold | 2 | 2000 | 51 | 0.020 |
Why?
|
Spiral Ganglion | 2 | 2001 | 180 | 0.020 |
Why?
|
Goiter | 1 | 1990 | 86 | 0.020 |
Why?
|
Dogs | 1 | 1995 | 3824 | 0.020 |
Why?
|
Craniocerebral Trauma | 1 | 1994 | 493 | 0.020 |
Why?
|
Computer Simulation | 2 | 2016 | 6252 | 0.020 |
Why?
|
Cross-Sectional Studies | 2 | 2011 | 26276 | 0.020 |
Why?
|
Transcription, Genetic | 3 | 2003 | 7599 | 0.020 |
Why?
|
Microscopy, Confocal | 1 | 2016 | 1965 | 0.020 |
Why?
|
Hospitals | 1 | 2003 | 3887 | 0.020 |
Why?
|
S100 Proteins | 1 | 1990 | 214 | 0.020 |
Why?
|
Hydrodynamics | 1 | 2011 | 163 | 0.020 |
Why?
|
Patient Satisfaction | 1 | 2002 | 3474 | 0.020 |
Why?
|
Sensitivity and Specificity | 3 | 2005 | 14644 | 0.020 |
Why?
|
DNA, Viral | 1 | 1996 | 2199 | 0.020 |
Why?
|
Vimentin | 1 | 1990 | 257 | 0.020 |
Why?
|
Neuroma | 1 | 1992 | 137 | 0.020 |
Why?
|
Schwann Cells | 1 | 1990 | 195 | 0.020 |
Why?
|
Nucleocapsid Proteins | 1 | 1989 | 75 | 0.020 |
Why?
|
Dosage Forms | 1 | 2009 | 55 | 0.020 |
Why?
|
Photography | 1 | 1992 | 535 | 0.020 |
Why?
|
Learning | 1 | 1999 | 1754 | 0.020 |
Why?
|
Trans-Activators | 1 | 1999 | 2849 | 0.020 |
Why?
|
Nucleoproteins | 1 | 1989 | 110 | 0.020 |
Why?
|
Mutation, Missense | 1 | 1998 | 2586 | 0.020 |
Why?
|
Sleep | 1 | 2005 | 4819 | 0.020 |
Why?
|
Base Sequence | 2 | 1998 | 12402 | 0.020 |
Why?
|
Chemokine CCL2 | 1 | 2011 | 602 | 0.020 |
Why?
|
Confusion | 1 | 2011 | 277 | 0.020 |
Why?
|
Periodicity | 1 | 2010 | 347 | 0.020 |
Why?
|
PPAR gamma | 1 | 2012 | 483 | 0.020 |
Why?
|
Tablets | 1 | 2009 | 149 | 0.020 |
Why?
|
Respiratory Syncytial Viruses | 1 | 1990 | 168 | 0.020 |
Why?
|
Postural Balance | 1 | 1993 | 637 | 0.020 |
Why?
|
Movement | 1 | 1995 | 1460 | 0.020 |
Why?
|
Hypoxanthine | 2 | 1998 | 28 | 0.020 |
Why?
|
Absorptiometry, Photon | 2 | 2008 | 1707 | 0.020 |
Why?
|
National Institute on Deafness and Other Communication Disorders (U.S.) | 1 | 2008 | 2 | 0.020 |
Why?
|
Receptors, Glutamate | 1 | 2009 | 227 | 0.020 |
Why?
|
Attitude of Health Personnel | 1 | 2002 | 3925 | 0.020 |
Why?
|
Cold Temperature | 1 | 2012 | 794 | 0.020 |
Why?
|
Ear Auricle | 1 | 2008 | 31 | 0.020 |
Why?
|
Celiac Disease | 1 | 1996 | 820 | 0.020 |
Why?
|
Task Performance and Analysis | 1 | 2012 | 771 | 0.020 |
Why?
|
Skin | 1 | 2002 | 4479 | 0.020 |
Why?
|
Incidence | 2 | 2016 | 21501 | 0.020 |
Why?
|
Chromosome Mapping | 1 | 1996 | 4618 | 0.020 |
Why?
|
Functional Laterality | 1 | 1994 | 2243 | 0.020 |
Why?
|
Monitoring, Physiologic | 1 | 1995 | 1794 | 0.020 |
Why?
|
Drug Administration Schedule | 1 | 2016 | 4849 | 0.020 |
Why?
|
Electronics | 1 | 2009 | 314 | 0.020 |
Why?
|
Water-Electrolyte Balance | 1 | 1989 | 326 | 0.020 |
Why?
|
Meningioma | 1 | 1996 | 1222 | 0.020 |
Why?
|
Polymorphism, Single Nucleotide | 1 | 2007 | 16040 | 0.020 |
Why?
|
Phosphorylation | 2 | 2012 | 8278 | 0.020 |
Why?
|
STAT3 Transcription Factor | 1 | 2011 | 871 | 0.020 |
Why?
|
Prospective Studies | 5 | 2013 | 54798 | 0.020 |
Why?
|
France | 1 | 2008 | 495 | 0.020 |
Why?
|
Laser-Doppler Flowmetry | 1 | 2007 | 236 | 0.020 |
Why?
|
Spain | 1 | 2008 | 483 | 0.020 |
Why?
|
Biocompatible Materials | 1 | 1995 | 1685 | 0.020 |
Why?
|
Vasculitis | 1 | 2011 | 523 | 0.020 |
Why?
|
Torque | 1 | 2007 | 132 | 0.020 |
Why?
|
Fiber Optic Technology | 1 | 1988 | 284 | 0.020 |
Why?
|
Follicle Stimulating Hormone | 1 | 2009 | 731 | 0.020 |
Why?
|
Pedigree | 3 | 2001 | 4528 | 0.020 |
Why?
|
Arterial Occlusive Diseases | 1 | 1991 | 758 | 0.020 |
Why?
|
Parotid Gland | 1 | 2007 | 177 | 0.020 |
Why?
|
Luteinizing Hormone | 1 | 2009 | 826 | 0.020 |
Why?
|
Immunoenzyme Techniques | 1 | 1989 | 1697 | 0.020 |
Why?
|
Vascular Endothelial Growth Factor A | 2 | 2012 | 3503 | 0.020 |
Why?
|
Radiation Tolerance | 1 | 1988 | 475 | 0.020 |
Why?
|
Nerve Tissue Proteins | 1 | 1999 | 4391 | 0.020 |
Why?
|
Veratridine | 1 | 2005 | 23 | 0.020 |
Why?
|
Monensin | 1 | 2005 | 30 | 0.020 |
Why?
|
Muscle Spindles | 1 | 2005 | 15 | 0.020 |
Why?
|
Tissue Engineering | 1 | 2016 | 1855 | 0.020 |
Why?
|
Calcimycin | 1 | 2005 | 214 | 0.020 |
Why?
|
Ionophores | 1 | 2005 | 108 | 0.020 |
Why?
|
6-Cyano-7-nitroquinoxaline-2,3-dione | 1 | 2005 | 55 | 0.020 |
Why?
|
Genotype | 2 | 2013 | 13023 | 0.020 |
Why?
|
Chemistry, Pharmaceutical | 1 | 2006 | 273 | 0.020 |
Why?
|
Neoplasm Invasiveness | 2 | 2007 | 3597 | 0.020 |
Why?
|
Specimen Handling | 1 | 1990 | 703 | 0.020 |
Why?
|
Ovariectomy | 1 | 1987 | 613 | 0.020 |
Why?
|
Phenylcarbamates | 1 | 2005 | 38 | 0.020 |
Why?
|
Chromatography, Liquid | 1 | 2009 | 991 | 0.020 |
Why?
|
Cytomegalovirus | 1 | 1990 | 752 | 0.020 |
Why?
|
Creatine Kinase | 1 | 2007 | 682 | 0.020 |
Why?
|
Hypothyroidism | 1 | 1990 | 665 | 0.020 |
Why?
|
Cardiovascular Diseases | 1 | 1991 | 15645 | 0.020 |
Why?
|
Fluorescent Antibody Technique | 1 | 1989 | 2470 | 0.020 |
Why?
|
Hair Cells, Auditory, Outer | 1 | 2005 | 98 | 0.010 |
Why?
|
Range of Motion, Articular | 1 | 2011 | 1595 | 0.010 |
Why?
|
Clinical Trials, Phase I as Topic | 1 | 2006 | 330 | 0.010 |
Why?
|
Clinical Trials as Topic | 2 | 2016 | 8039 | 0.010 |
Why?
|
Prosthesis Design | 2 | 2006 | 2112 | 0.010 |
Why?
|
Nuclear Proteins | 1 | 1999 | 5781 | 0.010 |
Why?
|
Reflex, Acoustic | 1 | 2004 | 34 | 0.010 |
Why?
|
Memory Disorders | 1 | 2011 | 1193 | 0.010 |
Why?
|
Cranial Fossa, Middle | 1 | 2004 | 29 | 0.010 |
Why?
|
Linear Models | 1 | 2014 | 5873 | 0.010 |
Why?
|
Homeostasis | 1 | 1995 | 3335 | 0.010 |
Why?
|
Fatal Outcome | 2 | 2001 | 1834 | 0.010 |
Why?
|
Proteins | 1 | 1998 | 5996 | 0.010 |
Why?
|
Proportional Hazards Models | 2 | 2005 | 12520 | 0.010 |
Why?
|
Gene Expression Regulation, Neoplastic | 1 | 2000 | 8601 | 0.010 |
Why?
|
Viral Load | 1 | 2013 | 3385 | 0.010 |
Why?
|
Monocarboxylic Acid Transporters | 1 | 2003 | 81 | 0.010 |
Why?
|
Thyroid Gland | 1 | 1990 | 1169 | 0.010 |
Why?
|
Risk Assessment | 1 | 2005 | 24278 | 0.010 |
Why?
|
Diabetes Mellitus, Type 2 | 1 | 2007 | 12235 | 0.010 |
Why?
|
Adjuvants, Immunologic | 1 | 2008 | 994 | 0.010 |
Why?
|
Confidence Intervals | 1 | 2008 | 2914 | 0.010 |
Why?
|
Synaptic Transmission | 1 | 2009 | 1175 | 0.010 |
Why?
|
Drug Therapy, Combination | 1 | 2013 | 6304 | 0.010 |
Why?
|
NF-kappa B | 1 | 2011 | 2487 | 0.010 |
Why?
|
Bone Marrow | 2 | 1994 | 2919 | 0.010 |
Why?
|
Bronchoscopy | 1 | 1988 | 908 | 0.010 |
Why?
|
Antibodies | 1 | 1991 | 2415 | 0.010 |
Why?
|
Oocytes | 1 | 1987 | 1167 | 0.010 |
Why?
|
Indoles | 2 | 2005 | 1832 | 0.010 |
Why?
|
Methods | 1 | 1983 | 1061 | 0.010 |
Why?
|
Partial Pressure | 1 | 2002 | 247 | 0.010 |
Why?
|
Viral Proteins | 1 | 1989 | 1798 | 0.010 |
Why?
|
Fascia | 1 | 2003 | 143 | 0.010 |
Why?
|
Oximetry | 1 | 2005 | 458 | 0.010 |
Why?
|
Middle Ear Ventilation | 1 | 2003 | 101 | 0.010 |
Why?
|
Genetic Testing | 1 | 1995 | 3590 | 0.010 |
Why?
|
Fatty Acids, Nonesterified | 1 | 2003 | 393 | 0.010 |
Why?
|
Mass Spectrometry | 1 | 2009 | 2194 | 0.010 |
Why?
|
Neoplasms | 1 | 1991 | 22349 | 0.010 |
Why?
|
Action Potentials | 1 | 2009 | 1837 | 0.010 |
Why?
|
Interleukin-6 | 1 | 2011 | 3228 | 0.010 |
Why?
|
Autoantibodies | 1 | 1990 | 2112 | 0.010 |
Why?
|
Pain Measurement | 1 | 2011 | 3559 | 0.010 |
Why?
|
Prevalence | 2 | 2015 | 15832 | 0.010 |
Why?
|
Sleep Stages | 1 | 2005 | 705 | 0.010 |
Why?
|
Transplantation, Autologous | 2 | 1996 | 2126 | 0.010 |
Why?
|
Mutation | 2 | 2003 | 30188 | 0.010 |
Why?
|
Perfusion | 1 | 2005 | 1408 | 0.010 |
Why?
|
Symporters | 1 | 2003 | 362 | 0.010 |
Why?
|
Ferritins | 1 | 2003 | 600 | 0.010 |
Why?
|
Fasting | 1 | 2007 | 1605 | 0.010 |
Why?
|
Aortic Bodies | 1 | 2000 | 2 | 0.010 |
Why?
|
Paraganglia, Nonchromaffin | 1 | 2000 | 3 | 0.010 |
Why?
|
Creatinine | 1 | 2006 | 1916 | 0.010 |
Why?
|
Thymidine Phosphorylase | 1 | 2000 | 16 | 0.010 |
Why?
|
AMP-Activated Protein Kinases | 1 | 2003 | 594 | 0.010 |
Why?
|
Diagnostic Imaging | 1 | 1994 | 3527 | 0.010 |
Why?
|
Tidal Volume | 1 | 2002 | 519 | 0.010 |
Why?
|
Immunoglobulins | 1 | 2003 | 852 | 0.010 |
Why?
|
Radiation Dosage | 1 | 1988 | 1944 | 0.010 |
Why?
|
Self Report | 1 | 2011 | 3768 | 0.010 |
Why?
|
Signal Processing, Computer-Assisted | 1 | 2007 | 1456 | 0.010 |
Why?
|
Neoplasm Staging | 2 | 2007 | 11205 | 0.010 |
Why?
|
Metformin | 1 | 2007 | 904 | 0.010 |
Why?
|
Carotid Body Tumor | 1 | 2000 | 34 | 0.010 |
Why?
|
Fertilization in Vitro | 1 | 1987 | 1301 | 0.010 |
Why?
|
Prognosis | 2 | 2014 | 29915 | 0.010 |
Why?
|
Epoetin Alfa | 1 | 1999 | 78 | 0.010 |
Why?
|
Phosphates | 1 | 2003 | 764 | 0.010 |
Why?
|
Eye Movements | 1 | 2002 | 510 | 0.010 |
Why?
|
Diabetes Mellitus | 1 | 1997 | 5889 | 0.010 |
Why?
|
CREB-Binding Protein | 1 | 1999 | 146 | 0.010 |
Why?
|
Autoimmune Diseases | 1 | 1991 | 2222 | 0.010 |
Why?
|
Inosine Monophosphate | 1 | 1998 | 7 | 0.010 |
Why?
|
Ergometry | 1 | 1998 | 17 | 0.010 |
Why?
|
Chromosome Disorders | 1 | 2001 | 498 | 0.010 |
Why?
|
Survival Analysis | 1 | 1991 | 10087 | 0.010 |
Why?
|
Bicuculline | 1 | 1998 | 94 | 0.010 |
Why?
|
Iontophoresis | 1 | 1998 | 74 | 0.010 |
Why?
|
Calcifediol | 1 | 1999 | 156 | 0.010 |
Why?
|
Logistic Models | 1 | 2013 | 13266 | 0.010 |
Why?
|
Adenine Nucleotides | 1 | 1998 | 110 | 0.010 |
Why?
|
Vascular Endothelial Growth Factors | 1 | 2000 | 754 | 0.010 |
Why?
|
Pharmaceutic Aids | 1 | 1997 | 7 | 0.010 |
Why?
|
Melanocytes | 1 | 2001 | 504 | 0.010 |
Why?
|
Norepinephrine | 1 | 2000 | 898 | 0.010 |
Why?
|
Microtomy | 1 | 1997 | 43 | 0.010 |
Why?
|
Tissue Embedding | 1 | 1997 | 43 | 0.010 |
Why?
|
Incus | 1 | 1997 | 19 | 0.010 |
Why?
|
Enzymes | 1 | 1999 | 254 | 0.010 |
Why?
|
Preservatives, Pharmaceutical | 1 | 1997 | 34 | 0.010 |
Why?
|
Histocytological Preparation Techniques | 1 | 1997 | 31 | 0.010 |
Why?
|
Probability | 1 | 1983 | 2475 | 0.010 |
Why?
|
Granulation Tissue | 1 | 1997 | 92 | 0.010 |
Why?
|
Oxidation-Reduction | 1 | 2003 | 2219 | 0.010 |
Why?
|
Endothelial Growth Factors | 1 | 2000 | 680 | 0.010 |
Why?
|
Rats, Long-Evans | 1 | 1998 | 380 | 0.010 |
Why?
|
Disease-Free Survival | 1 | 2007 | 6839 | 0.010 |
Why?
|
Epinephrine | 1 | 2000 | 782 | 0.010 |
Why?
|
Oxidative Phosphorylation | 1 | 1999 | 502 | 0.010 |
Why?
|
Rats, Inbred Strains | 1 | 1998 | 2077 | 0.010 |
Why?
|
Edetic Acid | 1 | 1997 | 274 | 0.010 |
Why?
|
Tissue Preservation | 1 | 1997 | 170 | 0.010 |
Why?
|
Anaerobiosis | 1 | 1997 | 140 | 0.010 |
Why?
|
Glucose | 1 | 1989 | 4332 | 0.010 |
Why?
|
Microelectrodes | 1 | 1998 | 305 | 0.010 |
Why?
|
Lymphokines | 1 | 2000 | 911 | 0.010 |
Why?
|
Physical Stimulation | 1 | 1998 | 513 | 0.010 |
Why?
|
Respiratory Physiological Phenomena | 1 | 1997 | 190 | 0.010 |
Why?
|
Chickens | 1 | 1998 | 842 | 0.010 |
Why?
|
Cerebellopontine Angle | 1 | 1996 | 53 | 0.010 |
Why?
|
Giant Cell Tumor of Bone | 1 | 1997 | 119 | 0.010 |
Why?
|
Doppler Effect | 1 | 1995 | 12 | 0.010 |
Why?
|
Radiotherapy, Adjuvant | 1 | 2001 | 1778 | 0.010 |
Why?
|
Weight Loss | 1 | 2007 | 2710 | 0.010 |
Why?
|
Randomized Controlled Trials as Topic | 1 | 2013 | 10383 | 0.010 |
Why?
|
Fibrous Dysplasia, Monostotic | 1 | 1995 | 8 | 0.010 |
Why?
|
Neurons, Afferent | 1 | 1998 | 496 | 0.010 |
Why?
|
Data Collection | 1 | 2005 | 3317 | 0.010 |
Why?
|
Lod Score | 1 | 1996 | 598 | 0.010 |
Why?
|
Microscopy, Fluorescence | 1 | 2003 | 2626 | 0.010 |
Why?
|
Visual Fields | 1 | 2002 | 1062 | 0.010 |
Why?
|
Protons | 1 | 2000 | 1073 | 0.010 |
Why?
|
Conserved Sequence | 1 | 1998 | 1159 | 0.010 |
Why?
|
Signal Transduction | 2 | 2012 | 23588 | 0.010 |
Why?
|
Administration, Topical | 1 | 1997 | 703 | 0.010 |
Why?
|
Fibrous Dysplasia, Polyostotic | 1 | 1995 | 39 | 0.010 |
Why?
|
Neocortex | 1 | 1999 | 414 | 0.010 |
Why?
|
Models, Theoretical | 1 | 2007 | 3563 | 0.010 |
Why?
|
Sulfonamides | 1 | 2005 | 1981 | 0.010 |
Why?
|
Brain Mapping | 2 | 2002 | 6598 | 0.010 |
Why?
|
Cell Line | 3 | 1996 | 15540 | 0.010 |
Why?
|
Strontium | 1 | 1994 | 22 | 0.010 |
Why?
|
Hyperplasia | 1 | 1998 | 1146 | 0.010 |
Why?
|
Freezing | 1 | 1995 | 310 | 0.010 |
Why?
|
Mass Screening | 1 | 1990 | 5445 | 0.010 |
Why?
|
Extracellular Matrix Proteins | 1 | 1998 | 833 | 0.010 |
Why?
|
Sequence Homology, Amino Acid | 1 | 1998 | 2744 | 0.010 |
Why?
|
Neurosurgical Procedures | 1 | 2005 | 2077 | 0.010 |
Why?
|
Medical History Taking | 1 | 1998 | 778 | 0.010 |
Why?
|
Nerve Compression Syndromes | 1 | 1995 | 159 | 0.010 |
Why?
|
CD-ROM | 1 | 1993 | 24 | 0.010 |
Why?
|
Bone Marrow Cells | 2 | 1994 | 2412 | 0.010 |
Why?
|
Glutens | 1 | 1996 | 240 | 0.010 |
Why?
|
Feasibility Studies | 1 | 2005 | 5302 | 0.010 |
Why?
|
Puberty | 1 | 1997 | 491 | 0.010 |
Why?
|
Fear | 1 | 2002 | 1496 | 0.010 |
Why?
|
Survival Rate | 1 | 2007 | 12821 | 0.010 |
Why?
|
Electrodes, Implanted | 1 | 1998 | 834 | 0.010 |
Why?
|
Brain Neoplasms | 1 | 1995 | 9069 | 0.010 |
Why?
|
Acute Disease | 1 | 2004 | 7237 | 0.010 |
Why?
|
Speech Reception Threshold Test | 1 | 1992 | 16 | 0.010 |
Why?
|
Speech Discrimination Tests | 1 | 1992 | 35 | 0.010 |
Why?
|
RNA | 1 | 2003 | 2716 | 0.010 |
Why?
|
Skull | 1 | 1997 | 814 | 0.010 |
Why?
|
Chemotherapy, Adjuvant | 1 | 2001 | 3539 | 0.010 |
Why?
|
Surface Properties | 1 | 1995 | 1153 | 0.010 |
Why?
|
Tissue Banks | 1 | 1993 | 183 | 0.010 |
Why?
|
Antibodies, Monoclonal | 1 | 1989 | 9241 | 0.010 |
Why?
|
Risk Factors | 3 | 1999 | 74853 | 0.010 |
Why?
|
Electromyography | 1 | 1997 | 1399 | 0.010 |
Why?
|
Prosthesis Failure | 1 | 1997 | 1195 | 0.010 |
Why?
|
Physical Examination | 1 | 1998 | 1263 | 0.010 |
Why?
|
Interprofessional Relations | 1 | 1998 | 998 | 0.010 |
Why?
|
Skin Transplantation | 1 | 1997 | 1098 | 0.010 |
Why?
|
Thalamus | 1 | 1998 | 1048 | 0.010 |
Why?
|
Cerebellar Neoplasms | 1 | 1996 | 571 | 0.010 |
Why?
|
Molecular Biology | 1 | 1995 | 574 | 0.010 |
Why?
|
Lasers | 1 | 1995 | 951 | 0.010 |
Why?
|
Ethanol | 1 | 1997 | 1324 | 0.010 |
Why?
|
Practice Guidelines as Topic | 2 | 1999 | 7416 | 0.010 |
Why?
|
Genetic Counseling | 1 | 1995 | 634 | 0.010 |
Why?
|
Monte Carlo Method | 1 | 1996 | 1238 | 0.010 |
Why?
|
Species Specificity | 1 | 1995 | 2406 | 0.010 |
Why?
|
Microcirculation | 1 | 1995 | 1279 | 0.010 |
Why?
|
Gadolinium | 1 | 1995 | 966 | 0.010 |
Why?
|
Laser Therapy | 1 | 1997 | 1109 | 0.010 |
Why?
|
Kidney | 1 | 2005 | 7073 | 0.010 |
Why?
|
Genes, Reporter | 1 | 1994 | 1524 | 0.010 |
Why?
|
National Institutes of Health (U.S.) | 1 | 1993 | 791 | 0.010 |
Why?
|
Biopsy, Needle | 1 | 1994 | 1614 | 0.010 |
Why?
|
Cerebral Angiography | 1 | 1995 | 1263 | 0.000 |
Why?
|
Age of Onset | 1 | 1996 | 3341 | 0.000 |
Why?
|
Forecasting | 1 | 1998 | 2938 | 0.000 |
Why?
|
Lymphocytes | 1 | 1996 | 2601 | 0.000 |
Why?
|
Pregnancy, Tubal | 1 | 1987 | 15 | 0.000 |
Why?
|
Transcription Factors | 1 | 2007 | 12122 | 0.000 |
Why?
|
Fluorescent Dyes | 1 | 1995 | 1929 | 0.000 |
Why?
|
Amino Acid Sequence | 1 | 1998 | 13402 | 0.000 |
Why?
|
Dose-Response Relationship, Radiation | 1 | 1988 | 868 | 0.000 |
Why?
|
Prostatic Neoplasms | 1 | 2009 | 11092 | 0.000 |
Why?
|
Sex Characteristics | 1 | 1997 | 2643 | 0.000 |
Why?
|
Prednisone | 1 | 1991 | 1562 | 0.000 |
Why?
|
Molecular Sequence Data | 1 | 1998 | 17595 | 0.000 |
Why?
|
Heart | 1 | 1997 | 4419 | 0.000 |
Why?
|
United States | 2 | 2008 | 72896 | 0.000 |
Why?
|
Communication | 1 | 1998 | 3906 | 0.000 |
Why?
|
Cost-Benefit Analysis | 1 | 1996 | 5529 | 0.000 |
Why?
|
Regression Analysis | 1 | 1992 | 6320 | 0.000 |
Why?
|
Abortion, Spontaneous | 1 | 1987 | 535 | 0.000 |
Why?
|
Polymers | 1 | 1989 | 1623 | 0.000 |
Why?
|
Cell Survival | 1 | 1988 | 5747 | 0.000 |
Why?
|
Databases, Factual | 1 | 1993 | 8062 | 0.000 |
Why?
|
Bone and Bones | 1 | 1985 | 2555 | 0.000 |
Why?
|
Infant | 1 | 1995 | 36375 | 0.000 |
Why?
|
Pregnancy | 1 | 1987 | 30215 | 0.000 |
Why?
|